发明名称 THERAPEUTIC AGENT FOR CANCER
摘要 When functional p53 is expressed in cancer even though the cancer develops SAC dysfunction, a CENP-E inhibitor is effective as a therapeutic agent for the cancer. The sensitivity of cancer to an CENP-E inhibitor can be determined by determining whether or not the cancer develops abnormality in SAC function and determining whether or not functional p53 is expressed in the cancer.
申请公布号 WO2012008507(A1) 申请公布日期 2012.01.19
申请号 WO2011JP66021 申请日期 2011.07.13
申请人 TAKEDA PHARMACEUTICAL COMPANY LIMITED;OHASHI, AKIHIRO 发明人 OHASHI, AKIHIRO
分类号 A61K45/00;A61P35/00;A61P43/00 主分类号 A61K45/00
代理机构 代理人
主权项
地址
您可能感兴趣的专利